Statements (70)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Hercules Technology Growth Capital
Bio-Rad Laboratories, Inc. Gene Expression, Inc. |
| gptkbp:ceo |
Ilan Daskal
|
| gptkbp:employees |
approximately 8,000
|
| gptkbp:focus |
life sciences
clinical diagnostics |
| gptkbp:founded |
gptkb:1952
|
| gptkbp:founder |
gptkb:David_Schwartz
|
| gptkbp:headquarters |
Hercules, California
Hercules, California, USA |
| https://www.w3.org/2000/01/rdf-schema#label |
Bio-Rad
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:operates_in |
global market
|
| gptkbp:partnership |
pharmaceutical companies
various academic institutions |
| gptkbp:product_line |
gptkb:Cell
gptkb:Poison DNA sequencing environmental testing biomarker discovery diagnostic tests food safety testing mass spectrometry cell-based assays enzyme assays flow cytometry cell culture products biochemical assays diagnostic imaging vaccine development microarray technology PCR reagents gel electrophoresis protein expression RNA analysis antibody production protein assays protein purification bioprocessing biomanufacturing protein characterization cell sorting gene editing tools molecular biology reagents biological reagents cell imaging cell line development clinical research tools cell analysis quality control products immunoassays biological buffers biological safety testing biological sample collection tools biological sample storage solutions cell preservation solutions gene therapy tools therapeutic development tools |
| gptkbp:products |
gptkb:software
laboratory instruments reagents |
| gptkbp:research_and_development |
significant investment
|
| gptkbp:revenue |
$2.5 billion (2022)
|
| gptkbp:stock_symbol |
BIO
|
| gptkbp:subsidiary |
Bio-Rad Laboratories, Inc.
|
| gptkbp:website |
www.bio-rad.com
|
| gptkbp:bfsParent |
gptkb:Gene_Amp_PCR_Systems
|
| gptkbp:bfsLayer |
9
|